In three particular scenarios—lower grade gliomas (LGG), uterine corpus EC (UCEC) and glioblastoma (GBM)—the effect was significant on OS and DFS for both PTEN loss and deletions. This evidence concerns the gene PTEN and central nervous system cancer.